The latest closing stock price for Contineum Therapeutics as of November 20, 2024 is 13.65.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $-114 today, roughly 0 times their original investment - a -11.36% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 61.2% above the current share price.
The Contineum Therapeutics 52-week low stock price is 12.33, which is 9.7% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 17.53.
An investor who bought $1,000 worth of Contineum Therapeutics stock at the IPO in 2024 would have $-114 today, roughly 0 times their original investment - a -11.36% compound annual growth rate over 1 years.
The all-time high Contineum Therapeutics stock closing price was 21.75 on July 16, 2024.
The Contineum Therapeutics 52-week high stock price is 22.00, which is 61.2% above the current share price.
The Contineum Therapeutics 52-week low stock price is 12.33, which is 9.7% below the current share price.
The average Contineum Therapeutics stock price for the last 52 weeks is 17.53.